Maria Hanl

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy

Fabian B. Kraft, Maria Hanl, Felix Feller et al. · Pharmaceuticals · 2023 · 25 citations · Full text

Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells

Fabian B. Kraft, Lukas Biermann, Linda Schäker‐Hübner et al. · Journal of Medicinal Chemistry · 2024 · 17 citations

Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile

Christoph Selg, Andrea Schöler, Julian Schliehe‐Diecks et al. · Chemical Science · 2021 · 12 citations · Full text

Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders

Felix Feller, Irina Honin, Martina Miranda et al. · Journal of Medicinal Chemistry · 2025 · 11 citations · Full text

Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers <b>DS-103</b> as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties

Daniel Stopper, Lukas Biermann, P. R. Watson et al. · Journal of Medicinal Chemistry · 2025 · 11 citations